Blood News and Research

RSS

Researchers identify four substances that inhibit SARS-CoV-2 replication in cells

Researchers from the German Center for Infection Research at Charité - Universitätsmedizin Berlin and the University of Bonn have examined the way in which SARS-CoV-2 reprograms the metabolism of the host cell in order to gain an overall advantage.

21 Jun 2021

COVID-19 studies should provide sex-disaggregated data, researchers warn

Researchers have warned that studies examining sex-specific responses to infection with SARS-CoV-2 must provide sex-disaggregated data.

21 Jun 2021

Study shows activation of CD16+ T-cells contribute to severe COVID-19 illness

Do T-cells play a protective immune role, or are they responsible for severe COVID-19 illness?

21 Jun 2021

Study shows that COVID-19 was present in five U.S. states in December 2019, even before the first reported case in China

In a recent study, a group of researchers aimed to identify exactly how early SARS-CoV-2 was circulating throughout the United States.

21 Jun 2021

New research uncovers substantial differences in rates of childhood cancers

New research uncovers substantial differences in rates of childhood cancers when considering single year of age rather than grouping several years together.

21 Jun 2021

Benefits of COVID-19 vaccination outweigh the complications, long-term effects of the disease

An international study, headed by Antonio Hernández, Professor of the Department of Legal Medicine, Toxicology and Physical Anthropology of the University of Granada, has reviewed the assessment reports of the European Medicines Agency regarding the Coronavirus vaccines produced by Pfizer, Moderna, and AstraZeneca.

21 Jun 2021

Study reveals how immune cells coordinate their swarming behavior to eliminate pathogens

The body is well protected against invading pathogens by barriers such as the skin. But if you injure yourself and break your skin, pathogens can easily enter your body through the wound and cause severe infections.

21 Jun 2021

Imperial College Healthcare NHS Trust partners with Luscii to provide at-home monitoring platform for heart failure patients

Imperial College Healthcare NHS Trust is working with remote healthcare innovator, Luscii to provide a cutting-edge, at-home monitoring platform to support patients with heart failure.

21 Jun 2021

Combination of doxycycline and TB drug treatment reduces the size of lung cavities

Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a regimen of at least six months of antimicrobial drugs, and drug-resistant TB is an increasing public health threat.

21 Jun 2021

New program reveals high burden of undiagnosed or poorly controlled diseases in rural South Africa

A comprehensive health-screening program in rural northern KwaZulu-Natal, South Africa, has found a high burden of undiagnosed or poorly controlled non-communicable diseases, according to a study published in The Lancet Global Health.

21 Jun 2021

New artificial heart can adjust the changing needs of patients treated for end-stage heart failure

An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure.

21 Jun 2021

Our commitment to a more sustainable future

As a UN Global Compact signatory member, Radiometer proudly continues to support the Ten Principles covering human rights, labour, environment and anti-corruption.

From Radiometer Medical 20 Jun 2021

New technique can measure metabolic process at the single-cell level

Understanding cellular metabolism - how a cell uses energy- could be key to treating a wide array of diseases, including vascular diseases and cancer.

18 Jun 2021

Common blood pressure drug not effective in reducing hospitalization for mildly-ill COVID-19 outpatients

University of Minnesota Medical School researchers determined that the common blood pressure medication, losartan, is not effective in reducing hospitalization for mildly-ill COVID-19 outpatients.

18 Jun 2021

Researchers assess the incidence of dementia or heart failure in people with rheumatoid arthritis

RA is an inflammatory autoimmune disease that causes pain, swelling and stiffness in the joints. It can also cause fatigue, and the underlying inflammation may affect other body systems.

18 Jun 2021

New hydrogel prevents the formation of adhesions after cardiac surgery

A hydrogel that forms a barrier to keep heart tissue from adhering to surrounding tissue after surgery was developed and successfully tested in rodents by a team of University of California San Diego researchers.

18 Jun 2021

Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

New research from scientists at the University of Pennsylvania, USA, demonstrates that cyclosporine A (CSA), a calcineurin inhibitor that modulates cytokine production, may have potential antiviral properties against coronaviruses.

18 Jun 2021

Could horse-derived antibody therapy be effective against SARS-CoV-2 variants of concern?

A new study, released as a preprint on the bioRxiv* server, reveals the high neutralizing efficacy of hyperimmune horse serum against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This could prove, if validated, to be a more affordable yet potent therapeutic in reducing the morbidity and mortality caused by this virus.

18 Jun 2021

Fighting the good fight –a new protein found in red blood cells linked to limiting cognitive decline

A new study shows that depleting mouse blood of the protein ADORA2B led to faster declines in memory, and increased brain inflammation.

18 Jun 2021

Convalescent plasma associated with better survival in blood cancer patients with COVID-19

Convalescent plasma therapy was associated with better survival in blood cancer patients hospitalized with COVID-19, especially in sicker patients. The findings by the COVID-19 and Cancer Consortium (CCC19) are newly published in the peer-reviewed journal JAMA Oncology.

18 Jun 2021

Blood News and Research

Researchers identify four substances that inhibit SARS-CoV-2 replication in cells

COVID-19 studies should provide sex-disaggregated data, researchers warn

Study shows activation of CD16+ T-cells contribute to severe COVID-19 illness

Study shows that COVID-19 was present in five U.S. states in December 2019, even before the first reported case in China

New research uncovers substantial differences in rates of childhood cancers

Benefits of COVID-19 vaccination outweigh the complications, long-term effects of the disease

Study reveals how immune cells coordinate their swarming behavior to eliminate pathogens

Imperial College Healthcare NHS Trust partners with Luscii to provide at-home monitoring platform for heart failure patients

Combination of doxycycline and TB drug treatment reduces the size of lung cavities

New program reveals high burden of undiagnosed or poorly controlled diseases in rural South Africa

New artificial heart can adjust the changing needs of patients treated for end-stage heart failure

Our commitment to a more sustainable future

New technique can measure metabolic process at the single-cell level

Common blood pressure drug not effective in reducing hospitalization for mildly-ill COVID-19 outpatients

Researchers assess the incidence of dementia or heart failure in people with rheumatoid arthritis

New hydrogel prevents the formation of adhesions after cardiac surgery

Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

Could horse-derived antibody therapy be effective against SARS-CoV-2 variants of concern?

Fighting the good fight –a new protein found in red blood cells linked to limiting cognitive decline

Convalescent plasma associated with better survival in blood cancer patients with COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News